BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Business

  goBalto, Inc. And Informa Partner To Accelerate Site Selection For Global Clinical Trials

  June 19, 2017

   · 

  4 min read
• Genetown

  Cerulean Distributes Letter To Stockholders Requesting Favorable Vote For Proposals At July 19, 2017 Special Shareholder Meeting

  June 19, 2017

   · 

  6 min read
• New Study Compares Performance Of Masimo Next Generation Sedline Patient State Index (PSi) To Original PSi During Anesthesia

  June 19, 2017

   · 

  7 min read
• FDA

  Horizon Pharma Announces Health Canada Approval Of PROCYSBI (Cysteamine Delayed-Release Capsules) For The Treatment Of Nephropathic Cystinosis

  June 19, 2017

   · 

  4 min read
• Genetown

  Syros Pharma Presents Discovery Of Key Genes Controlling The Autoimmune Response In Lupus In Late-Breaking Oral Presentation At FOCIS Meeting

  June 19, 2017

   · 

  6 min read
• Drug Development

  Pfizer Begins Phase I Clinical Trial To Evaluate Investigational Group B Streptococcus Vaccine

  June 19, 2017

   · 

  7 min read
• Genetown

  Frequency Therapeutics Presented Data At The International Society For Stem Cell Research Supporting Progenitor Cell Activation To Restore Healthy Function In Multiple Tissue Types

  June 19, 2017

   · 

  4 min read
• Business

  Selecta Announces Addition Of Patrick J. Zenner To Board Of Directors

  June 19, 2017

   · 

  3 min read
• Biotech Beach

  BioTrace Medical’s Tempo Lead Shows Stability And Safety In Real-World Performance Consistent With Clinical Study Outcomes In TVT 2017 Presentation

  June 19, 2017

   · 

  4 min read
• Drug Development

  Genexine Co. Ltd. Receives Approval To Initiate Phase Ib/II Trial Of GX-188E, HPV Therapeutic DNA Vaccine, In Combination With KEYTRUDA (Pembrolizumab), For The Treatment Of HPV-Induced Cervical Cancer

  June 19, 2017

   · 

  3 min read